share on google plus
Text size
view with small font size
view with medium font size
view with large font size

Respect for Human Rights

Raising Human Rights Awareness

Our activities to raise employee awareness of human rights are based on the policies and measures determined by the Kirin Group Human Rights Promotion Committee*1, in which Kyowa Hakko Kirin participates as a member. Our human rights awareness building program, for example, was launched in 2009, and has also been introduced at Kyowa Hakko Bio and other Kyowa Hakko Kirin Group companies. Moreover, awareness building programs on LGBT (lesbian, gay, bisexual and transgender) issues are also offered. In July 2017, we established the Kyowa Hakko Kirin Group Human Rights Promotion Committee*2 with the aim of raising employee awareness of the importance of human rights throughout the Group.

Other efforts to raise human rights awareness include conducting the Kirin Group Compliance/Human Rights Awareness Survey in conjunction with all other Kirin Group companies; sharing a message from the president to employees during Harassment Elimination Month; and soliciting slogans from employees for Human Rights Week. We have also established an internal reporting contact, where employees can call to report or seek advice on harassment and other human rights issues. Such efforts are aimed at eliminating harassment from workplaces and enhancing the corporate culture.

A committee chaired by the human resources director of Kirin Holdings and staffed by human resources department managers from major companies within the Kirin Group.
A committee chaired by the director of Kyowa Hakko Kirin’s Human Resources Department and staffed by human resources department managers from major subsidiaries of Kyowa Hakko Kirin.

Ensuring Human Rights throughout Our Value Chain

Kyowa Hakko Kirin is endeavoring to ensure human rights throughout its pharmaceutical value chain.

Human rights considerations in research

Kyowa Hakko Kirin sets internal rules with the aim of assuring ethical and scientific validity in human genome analysis and research using human tissue as well as preventing the loss of dignity and protecting the human rights of tissue donors.

Safeguarding human rights in clinical trials

When conducting a clinical trial involving human subjects, Kyowa Hakko Kirin, pursuant to the Declaration of Helsinki, gives top priority to protecting the human rights and personal information of patients participating in the trial, securing their safety, and giving consideration to their welfare, and complies with the laws and regulations and Good Clinical Practices (GCP) guidelines of the applicable countries.

Ensuring human rights in purchasing activities

We have formulated the “Kyowa Hakko Kirin Group Procurement Policy” and the “Kyowa Hakko Kirin CSR Procurement Guidebook” to help us ensure human rights throughout the supply chain in collaboration with our suppliers.

Ensuring human rights in production activities

We have established the Kyowa Hakko Kirin Group Basic Policy on the Environment, Safety and Product Safety with the aim of securing the safety of local residents living in the neighborhood of our plants as well as our employees.

Ensuring human rights in engaging with medical institutions and patient organizations

Pursuant to the Kyowa Hakko Kirin Group Compliance Policy, we act with high ethical standards and in the best interest of patients when we engage with medical institutions and patient organizations.

To Page Top